-
Something wrong with this record ?
Variation of selected genotoxic and epigenetic markers due to therapeutic exposure to PAHs and ultraviolet radiation
P. Borsky, M. Chmelarova, Z. Fiala, V. Palicka, M. Beranek, J. Kremlacek, C. Andrys, K. Hamakova, A. Malkova, L. Borska
Language English Country Slovakia
Document type Clinical Study, Research Support, Non-U.S. Gov't
- Keywords
- Goeckermanova terapie,
- MeSH
- 5-Methylcytosine blood MeSH
- DNA Adducts blood MeSH
- Coal Tar adverse effects MeSH
- Adult MeSH
- Genetic Markers drug effects radiation effects MeSH
- Humans MeSH
- DNA Methylation drug effects radiation effects MeSH
- Tumor Suppressor Protein p53 blood MeSH
- Polycyclic Aromatic Hydrocarbons * adverse effects MeSH
- Psoriasis drug therapy complications radiotherapy MeSH
- Ultraviolet Therapy * adverse effects MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Clinical Study MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND: Goeckerman therapy (GT) of psoriasis involves dermal application of crude coal tar containing polycyclic aromatic hydrocarbons (PAHs) and exposure to ultraviolet radiation (UVR). Little is known about GT influence on DNA epigenetics. OBJECTIVE: The study aim was to discover epigenetic mechanisms altered by the exposure related to the GT of psoriasis. METHODS: Observed group of patients with plaque psoriasis (n = 23) was treated by GT with 3 % CCT. Before and after GT, we analyzed the levels of benzo[a]pyrene-7,8-diol-9,10-epoxide-DNA adducts (BPDE-DNA), p53 protein in serum, 5-methylcytosine (5-mC, global DNA methylation), and methylation in selected CpG sites of p53 gene. RESULTS: We found a significant increase in the levels of BPDE-DNA (p < 0.01) and serum levels of p53 protein (p < 0.01) after GT, and an insignificant decrease in the percentage of 5-mC in peripheral blood DNA. Methylation of p53 CpG sites was affected neither by psoriasis nor by GT. The study confirmed good effectiveness of GT (significantly reduced psoriasis area and severity index; p < 0.001). CONCLUSION: Our findings indicate that there is a significantly increased genotoxic hazard related to the exposure of PAHs and UV radiation after GT of psoriasis. However, global DNA methylation and p53 gene methylation evade the effect of GT, as they remained unchanged (Tab. 4, Fig. 3, Ref. 50).
References provided by Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21026818
- 003
- CZ-PrNML
- 005
- 20250217015108.0
- 007
- cr|cn|
- 008
- 211014s2020 xo d fs 000 0|eng||
- 009
- AR
- 024 0_
- $a 10.4149/BLL_2020_093 $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xo
- 100 1_
- $a Borský, Pavel, $d 1992- $7 xx0268728 $u Institute of Hygiene and Preventive Medicine, Charles University in Prague, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic $u Institute of Pathological Physiology, Charles University in Prague, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic
- 245 10
- $a Variation of selected genotoxic and epigenetic markers due to therapeutic exposure to PAHs and ultraviolet radiation / $c P. Borsky, M. Chmelarova, Z. Fiala, V. Palicka, M. Beranek, J. Kremlacek, C. Andrys, K. Hamakova, A. Malkova, L. Borska
- 504 __
- $a Literatura
- 520 9_
- $a BACKGROUND: Goeckerman therapy (GT) of psoriasis involves dermal application of crude coal tar containing polycyclic aromatic hydrocarbons (PAHs) and exposure to ultraviolet radiation (UVR). Little is known about GT influence on DNA epigenetics. OBJECTIVE: The study aim was to discover epigenetic mechanisms altered by the exposure related to the GT of psoriasis. METHODS: Observed group of patients with plaque psoriasis (n = 23) was treated by GT with 3 % CCT. Before and after GT, we analyzed the levels of benzo[a]pyrene-7,8-diol-9,10-epoxide-DNA adducts (BPDE-DNA), p53 protein in serum, 5-methylcytosine (5-mC, global DNA methylation), and methylation in selected CpG sites of p53 gene. RESULTS: We found a significant increase in the levels of BPDE-DNA (p < 0.01) and serum levels of p53 protein (p < 0.01) after GT, and an insignificant decrease in the percentage of 5-mC in peripheral blood DNA. Methylation of p53 CpG sites was affected neither by psoriasis nor by GT. The study confirmed good effectiveness of GT (significantly reduced psoriasis area and severity index; p < 0.001). CONCLUSION: Our findings indicate that there is a significantly increased genotoxic hazard related to the exposure of PAHs and UV radiation after GT of psoriasis. However, global DNA methylation and p53 gene methylation evade the effect of GT, as they remained unchanged (Tab. 4, Fig. 3, Ref. 50).
- 650 07
- $a dospělí $7 D000328 $2 czmesh
- 650 07
- $a ženské pohlaví $7 D005260 $2 czmesh
- 650 07
- $a lidé $7 D006801 $2 czmesh
- 650 07
- $a mužské pohlaví $7 D008297 $2 czmesh
- 650 07
- $a genetické markery $x účinky léků $x účinky záření $7 D005819 $2 czmesh
- 650 17
- $a polycyklické aromatické uhlovodíky $x škodlivé účinky $7 D011084 $2 czmesh
- 650 17
- $a terapie ultrafialovými paprsky $x škodlivé účinky $7 D014467 $2 czmesh
- 650 07
- $a psoriáza $x farmakoterapie $x komplikace $x radioterapie $7 D011565 $2 czmesh
- 650 07
- $a dehet uhelný $x škodlivé účinky $7 D003033 $2 czmesh
- 650 07
- $a metylace DNA $x účinky léků $x účinky záření $7 D019175 $2 czmesh
- 650 07
- $a adukty DNA $x krev $7 D018736 $2 czmesh
- 650 07
- $a nádorový supresorový protein p53 $x krev $7 D016159 $2 czmesh
- 650 07
- $a 5-methylcytosin $x krev $7 D044503 $2 czmesh
- 653 00
- $a Goeckermanova terapie
- 655 _7
- $a klinická studie $7 D000068397 $2 czmesh
- 655 _7
- $a práce podpořená grantem $7 D013485 $2 czmesh
- 700 1_
- $a Chmelařová, Marcela, $d 1985- $7 xx0191598 $u Institute of Clinical Biochemistry and Diagnostics, Charles University Hospital and Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic
- 700 1_
- $a Fiala, Zdeněk, $d 1955- $7 nlk19990073147 $u Institute of Hygiene and Preventive Medicine, Charles University in Prague, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic
- 700 1_
- $a Palička, Vladimír, $d 1946- $7 jn99240000830 $u Institute of Clinical Biochemistry and Diagnostics, Charles University Hospital and Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic
- 700 1_
- $a Beránek, Martin, $d 1968- $7 xx0044204 $u Institute of Clinical Biochemistry and Diagnostics, Charles University Hospital and Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic $u Department of Biochemical Sciences, Charles University in Prague, Faculty of Pharmacy in Hradec Kralove, Hradec Kralove, Czech Republic
- 700 1_
- $a Kremláček, Jan, $d 1967- $7 mzk2003171485 $u Institute of Pathological Physiology, Charles University in Prague, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic
- 700 1_
- $a Andrýs, Ctirad, $d 1962- $7 mzk2008430528 $u Institute of Clinical Immunology and Allergology, Charles University in Prague, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic
- 700 1_
- $a Hamáková, Květoslava $7 xx0064204 $u Clinic of Dermal and Venereal Diseases, Charles University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
- 700 1_
- $a Málková, Andrea $7 xx0230140 $u Institute of Hygiene and Preventive Medicine, Charles University in Prague, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic
- 700 1_
- $a Borská, Lenka $7 nlk20060173900 $u Institute of Pathological Physiology, Charles University in Prague, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic
- 773 0_
- $t Bratislavské lekárske listy $x 0006-9248 $g Roč. 121, č. 8 (2020), s. 558-564 $w MED00000845
- 856 41
- $u http://www.elis.sk/download_file.php?product_id=6839&session_id=vqcv5omiqd8n4relp2g02i6ia2 $y plný text volně přístupný
- 910 __
- $a ABA008 $b online $c 1067 $y p $z 0
- 990 __
- $a 20211012144111 $b ABA008
- 991 __
- $a 20250217015106 $b ABA008
- 999 __
- $a ok $b bmc $g 1708791 $s 1147326
- BAS __
- $a 3 $a 4
- BMC __
- $a 2020 $b 121 $c 8 $d 558-564 $i 0006-9248 $m Bratislavské lekárske listy $x MED00000845
- LZP __
- $c NLK189 $d 20250217 $a NLK 2021-43/kv